October is Pituitary Awareness Month!
Join us for Live-talk Thursdays, October 13, at 3:00 pm PST. Using his clinical experiences, Dr. Lewis Blevins will focus the discussion on hypercortisolism and the latest management practices. Stay tuned for more Pituitary disease awareness initiatives.
Read more about Live Talk here and Listen to our past sessions on demand.
Articles of note for people dealing with pituitary disease and related conditions.
Join a drug trial. Find out how. Here’s a partial list of studies.
Brief, insightful commentary from Dr. Lewis Blevins on issues of relevance to pituitary disease.
[test_posts category=”featured”]
[test_posts category=”featured” offset=”1″ class=”sub-category” number=”2″]
News In Brief
Amryt Pharma relaunches its patient-facing website for Mycapssa
Two surveys from COR2ED explore somatostatin injection experiences by people living with acromegaly and NETs. To learn the details and participate, follow the links. Patient/caregiver survey: HERE; HCP survey: HERE
Recordati Rare Diseases Phase III study confirms the efficacy and safety of ISTURISA®. achieving sustained cortisol control in the majority of patients. Read more
Corcept Therapeutics announces new communication materials for Phase 3 Trial of Relacolirant in patients with Cushing’s syndrome. Click here to learn more and see if you qualify.
Crinetics Pharmaceuticals moves forward with Paltusotine® phase 3 study. To learn more about the trial and see if you qualify, read more here.
Content for physicians and healthcare professionals.
The latest from pharmaceutical companies and related organizations
Latest trends and a roundup of health and wellness news
The Podcast
Knowledge and information are critical tools to affect early diagnosis in pituitary disease. Join Dr. Lewis Blevins and Jorge D Faccinetti cofounders, as they navigate the wonders and complexities of pituitary conditions.
In today’s podcast, Dr. Lewis Blevins dives into the fascinating findings from a study by Corcept Therapeutics on the prevalence of hypercortisolism in people with type 2 diabetes.
This is a very informative discussion about the new indications of the Cushing's Drug Isturisa® (osilodrostat) with Dr. Mario Maldonado, who heads global development for endocrinology at Recordati Rare Diseases.
Subscribe & Listen
Apple Podcasts
Spotify
Amazon Music
Google PodcastsLive Talk on Demand
Most Popular Articles
Events
October 17, 5:00 to 6:00 pm CET. Jill Sisco, president of Acromegaly Community, talks about navigating medicare. Register here.
NYU Acromegaly patient education day. Join us on October 29, 2022, from 8 am to 1 pm EDT, for an Acromegaly Educational Day! Register here
